Veto Process
No veto information available
Team Singularity Female
| Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|
| Ked | 215 | 38 / 30 / 4 | 133 | 74% | 2 - 1 | 23% |
| ESTEE | 172 | 22 / 28 / 12 | 124 | 67% | 1 - 2 | 24% |
| minemosynE | 224 | 34 / 34 / 6 | 137 | 70% | 8 - 5 | 19% |
| Nariel | 177 | 24 / 37 / 14 | 129 | 57% | 6 - 8 | 18% |
| Lakhesis | 146 | 20 / 32 / 15 | 103 | 59% | 5 - 5 | 27% |
| Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|
| Ked | 215 | 38 / 30 / 4 | 133 | 74% | 2 - 1 | 23% |
| ESTEE | 172 | 22 / 28 / 12 | 124 | 67% | 1 - 2 | 24% |
| minemosynE | 224 | 34 / 34 / 6 | 137 | 70% | 8 - 5 | 19% |
| Nariel | 177 | 24 / 37 / 14 | 129 | 57% | 6 - 8 | 18% |
| Lakhesis | 146 | 20 / 32 / 15 | 103 | 59% | 5 - 5 | 27% |
Team Singularity Female
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
Ked | 235 | 24 / 16 / 2 | 151 | 79% | 1 - 1 | 25% |
|
ESTEE | 164 | 12 / 15 / 8 | 116 | 75% | 1 - 2 | 32% |
|
minemosynE | 204 | 17 / 18 / 5 | 125 | 71% | 4 - 1 | 13% |
|
Nariel | 204 | 16 / 19 / 10 | 138 | 67% | 3 - 6 | 16% |
|
Lakhesis | 135 | 11 / 18 / 10 | 94 | 71% | 2 - 3 | 26% |
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
Ked | 235 | 24 / 16 / 2 | 151 | 79% | 1 - 1 | 25% |
|
ESTEE | 164 | 12 / 15 / 8 | 116 | 75% | 1 - 2 | 32% |
|
minemosynE | 204 | 17 / 18 / 5 | 125 | 71% | 4 - 1 | 13% |
|
Nariel | 204 | 16 / 19 / 10 | 138 | 67% | 3 - 6 | 16% |
|
Lakhesis | 135 | 11 / 18 / 10 | 94 | 71% | 2 - 3 | 26% |
Team Singularity Female
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
minemosynE | 243 | 17 / 16 / 1 | 148 | 68% | 4 - 4 | 25% |
|
Ked | 195 | 14 / 14 / 2 | 115 | 68% | 1 - 0 | 21% |
|
ESTEE | 179 | 10 / 13 / 4 | 131 | 58% | 0 - 0 | 16% |
|
Lakhesis | 156 | 9 / 14 / 5 | 112 | 47% | 3 - 2 | 27% |
|
Nariel | 149 | 8 / 18 / 4 | 120 | 47% | 3 - 2 | 20% |
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
minemosynE | 243 | 17 / 16 / 1 | 148 | 68% | 4 - 4 | 25% |
|
Ked | 195 | 14 / 14 / 2 | 115 | 68% | 1 - 0 | 21% |
|
ESTEE | 179 | 10 / 13 / 4 | 131 | 58% | 0 - 0 | 16% |
|
Lakhesis | 156 | 9 / 14 / 5 | 112 | 47% | 3 - 2 | 27% |
|
Nariel | 149 | 8 / 18 / 4 | 120 | 47% | 3 - 2 | 20% |